Chrysos Lifts Revenue 27% on Sample Growth
Chrysos Corporation reported unaudited revenue of $36.7 million for the first four months of FY2027, driven by higher sample volumes on its PhotonAssay fleet.
Updated on Nov. 19, 2026 in Public Companies

Chrysos Corporation's unaudited revenue for the first four months of FY2027 rose 27% to $36.7 million. The company signed 15 new PhotonAssay lease agreements this financial year, bringing its units under contract to 97.
Why it matters
Revenue growth came mainly from customers processing more samples through existing machines, which lifted usage-based charges. The company's guidance and expansion targets depend on whether that usage trend continues across the installed fleet.
Minimum monthly assay payments reached $22.6 million, up 7%, while additional assay charges rose 79% to $13.7 million, making usage-based charges 38% of PhotonAssay revenue versus 26% a year earlier. Cash held at 31 October was $19.5 million, and the figures remain unaudited.
The players
Chrysos Corporation
Chrysos Corporation is a company that operates the PhotonAssay analysis system and leases it to miners and laboratory partners.
The details
Customers pay minimum monthly assay payments under contract and additional charges for sample volumes above those minimums. October 2026 set a monthly record of 1.36 million samples, and the fleet sustained above 90% availability from July to October.
Timeline
July to October 2026: Fleet analysed 4.91 million samples, up 43% year over year.
August 2026: Company published its August results; eleven of the 15 new leases were signed after that release.
31 October 2026: Company held $19.5 million in cash.
Market Landscape
Chrysos's revenue model depends on usage-based charges from its PhotonAssay fleet rather than on one-time equipment sales. The growth in additional assay charges indicates that the lease structure is shifting revenue toward volume-linked income.
For customers, the lease model means costs rise with sample volume, so operators running more samples through the fleet face higher additional charges. For investors, the figures are unaudited and the company's forward targets depend on continued volume growth.
The takeaway
Revenue growth at Chrysos is tracking sample volume more than fleet size, so the rate at which customers process samples is a useful signal to watch. Unaudited results can shift, so readers should weigh the company's targets against audited figures when they become available.
What happens next
Chrysos Corporation has set FY2027 revenue guidance of $108 million to $118 million and EBITDA of $35 million to $42 million on a constant-currency basis.
Further reading
Explore more Public Companies coverage to see how other listed firms are reporting growth.
Source note: This article includes information reported by Small Caps.



